Skip to main content

Olainfarm confirmed the compliance with Russian Good Manufacturing Practice (GMP)

JSC Olainfarm has received Russian certificate of Good Manufacturing Practice which confirms the company’s care for the quality system, including the maintenance of requirements for the production and quality control of medicines, and compliance with the market of Russia. The receiving of the certificate gives the opportunity for the company to fully continue operations in Russia, which is one of Olainfarm’s key export markets.
“The company is taking care of the product quality compliance with both international and national standards, including the requirements of the European Union and Russian regulations. Receipt of the certificate allows the company to continue achieving its goals. Special thanks to colleagues who have been working long-term to ensure that the company is meeting the highest standarts,” says Raimonds Terentjevs, Member of the Board of JSC Olainfarm and Director of the Quality Management Department.“One of the goals and tasks of Olainfarm is to build trust with customers by producing quality products in accordance with the requirements of Good Manufacturing Practices. Investments in the development and modernization of the company, as well as the work of all our team, allow Olainfarm to be among the pharmaceutical companies that received the Russian Good Manufacturing Practice Certificate in October. In 2019, 32% of Olainfarm’s products were exported to Russia, in line with quality requirements and a high sense of responsibility for human health and well-being. Receiving of the certificate is especially important because that way, the company has a strategically important position by combining compliance with Russian and European requirements,” emphasized Milana Beļeviča, Member of the Board of JSC Olainfarm.JSC Olainfarm is equipped with modern technologies and certified in accordance with the requirements of Good Manufacturing Practice of Russia and EU, the Environmental Management Standard ISO 14001:2015, laboratory standard ISO 17025, in separate categories – US inspection standards (FDA), inspection standards of Australia (TGA) and Japan (PMDA). The Russian GMP Certificate is issued for three years.JSC Olainfarm is one of the largest companies in the Baltic States with more than 45 years of experience in the production of medicines and chemical pharmaceutical products. The basic principle of the company’s activity is to produce reliable and efficient products of the highest quality for Latvia and the whole world. Currently, the products of JSC Olainfarm are exported to more than 50 countries and territories of the world, including the Baltic States, Russia, other CIS countries, Europe, North America, Asian countries and Australia.Additional information:  
Jānis Dubrovskis
Investor Relations Advisor of JSC Olainfarm
Phone: +371 29178878
Email: janis.dubrovskis@olainfarm.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.